AnPac Bio: Rises as lab gets FDA approval to start COVID-19 testing

Fresh2

10/11/2020 14:26

** U.S.-listed shares of Chinese biotech co  ANPC.O  rise 
9.27% to $3.89 premarket
    ** Co says its laboratory in San Jose, California, has
completed a U.S. FDA emergency use authorization verification
for a COVID-19 antibody test from Roche Holding  ROG.S  called
Elecsys  urn:newsml:reuters.com:*:nGNX7pB56t
    ** As part of FDA protocol, successful verification of an
antibody test means that ANPC can now enter into the commercial
testing stage
    ** ANPC calls the verification a major milestone, which
signifies it has entered into its commercialization and revenue
generation phase in U.S. - CEO Chris Yu

 (Reporting by Vishwadha Chander in Bengaluru)
 ((Vishwadha.Chander@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 80 6749 6132;))